Reblozyl (luspatercept)

pCPA File Number: 21686
Negotiation Status:
Under consideration for negotiation
Indication(s):
transfusion dependent anemia associated with MDS
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0670-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable